×
Home Companies Industry Politics Money Opinion LoungeMultimedia Science Education Sports TechnologyConsumerSpecialsMint on Sunday
×

Regulator for price cap on anti-cancer drugs

Regulator for price cap on anti-cancer drugs
Comment E-mail Print Share
First Published: Wed, Jan 06 2010. 11 33 PM IST
Updated: Wed, Jan 06 2010. 11 33 PM IST
New Delhi: Drugs Controller General of India has recommended a price cap on anti-cancer medicines, a government source person familiar with the matter said on Wednesday.
“The regulator has written to the director general health services to include anti-cancer drugs in the list of essential medicines that are under price control,” the person said.
The move is likely to hurt margins of companies such as GlaxoSmithKline Pharmaceuticals Ltd Eli Lilly and Co. Ltd, and Pfizer Inc., who have major drugs in the category.
A final decision on this issue will have to be taken by the group of ministers on pharmaceutical policy.
Comment E-mail Print Share
First Published: Wed, Jan 06 2010. 11 33 PM IST